Premenopausal advantages in postprandial lipid metabolism are lost in women with type 2 diabetes.

OBJECTIVE Women with type 2 diabetes appear to lose the protection against cardiovascular disease afforded by estrogens. We examined the effects of menopausal status on postprandial clearance of dietary fat in healthy and diabetic women. RESEARCH DESIGN AND METHODS Fasting subjects (premenopausal and postmenopausal control subjects, premenopausal and postmenopausal diabetic women, all n = 8) were given a meal containing the stable isotope 1,1,1-(13)C-tripalmitin, with blood and breath sampled for 6 and 24 h, respectively, in the postprandial period. Lower levels of (13)C-palmitic acid ((13)C-PA) in the triglyceride fraction implies more efficient chylomicron clearance, lower levels of (13)C-PA in the nonesterified fatty acid (NEFA) fraction implies improved dietary NEFA entrapment, and higher levels of (13)CO(2) in the breath denote more efficient of oxidation of dietary-derived lipid. RESULTS In diabetic women, there were no differences between the pre- and postmenopausal groups for any of these parameters. In contrast, premenopausal control subjects, compared with postmenopausal control subjects, had lower (13)C-PA in the triglyceride fraction area under the curve (AUC) (premenopausal median [range] 25.2 [12.1-49.4 mmol/l] per 6 h, postmenopausal 48.5 [15.5-77.2 mmol/l] per 6 h; P < 0.01) and higher (13)CO(2) levels in the breath AUC (premenopausal 22.5 [18.0-31.5%] of administered dose, postmenopausal 17.2 [11.2-31.5%] of administered dose; P < 0.01) with no difference between groups in levels of (13)C-PA in the NEFA fraction AUC. CONCLUSIONS The premenopausal advantage in clearance of dietary lipid is not seen in premenopausal diabetic women. This is likely to promote an atherogenic lipoprotein profile and may contribute to the loss of cardiovascular disease protection seen in diabetic women.

[1]  S. Wootton,et al.  Conversion of α-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women , 2002, British Journal of Nutrition.

[2]  E. Schaefer,et al.  Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects. , 2002, The American journal of cardiology.

[3]  Peter Libby,et al.  Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. , 2002, JAMA.

[4]  M. Febbraio,et al.  Effect of ovarian hormones on mitochondrial enzyme activity in the fat oxidation pathway of skeletal muscle. , 2001, American journal of physiology. Endocrinology and metabolism.

[5]  K. Friday,et al.  Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes. , 2001, The Journal of clinical endocrinology and metabolism.

[6]  S. Wootton,et al.  A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction* , 2000, British Journal of Nutrition.

[7]  A. V. van Beek,et al.  Menopause is associated with reduced protection from postprandial lipemia. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[8]  H. E. Westerveld Estrogens and postprandial lipid metabolism. , 1998, Atherosclerosis.

[9]  M. Kilgore,et al.  Estrogen regulation of adipose tissue lipoprotein lipase--possible mechanism of body fat distribution. , 1998, American journal of obstetrics and gynecology.

[10]  S. Roberts,et al.  Fat oxidation in response to four graded energy challenges in younger and older women. , 1997, The American journal of clinical nutrition.

[11]  K. Frayn Metabolic Regulation: A Human Perspective , 1996 .

[12]  T. D. de Bruin,et al.  Triglyceride‐rich lipoproteins in non‐insulin‐dependent diabetes mellitus: post‐prandial metabolism and relation to premature atherosclerosis , 1996, European journal of clinical investigation.

[13]  A. Hardman,et al.  Walking During the Postprandial Period Decreases Alimentary Lipaemia , 1995, Journal of cardiovascular risk.

[14]  T. D. de Bruin,et al.  17 beta-Estradiol improves postprandial lipid metabolism in postmenopausal women. , 1995, The Journal of clinical endocrinology and metabolism.

[15]  J. Simoneau,et al.  Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. , 1994, The Journal of clinical investigation.

[16]  Z. Kendrick,et al.  Effects of estradiol on lipoprotein lipase activity and lipid availability in exercised male rats. , 1994, Journal of applied physiology.

[17]  M. Taskinen,et al.  Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[18]  P. Roach,et al.  Modulation of the low-density-lipoprotein-receptor-related protein and its relevance to chylomicron-remnant metabolism. , 1992, The Biochemical journal.

[19]  P. Demacker,et al.  Increased hepatic lipase activity and increased direct removal of very-low-density lipoprotein remnants in Watanabe heritable hyperlipidaemic (WHHL) rabbits treated with ethinyl oestradiol. , 1990, The Biochemical journal.

[20]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[21]  Graham A. Colditz,et al.  Menopause and Heart Disease , 1990 .

[22]  S Senn,et al.  Analysis of serial measurements in medical research. , 1990, BMJ.

[23]  W. Willett,et al.  Menopause and heart disease. A review. , 1990, Annals of the New York Academy of Sciences.

[24]  K. Matthews,et al.  Menopause and risk factors for coronary heart disease. , 1990, The New England journal of medicine.

[25]  T. Wolever,et al.  Nibbling versus gorging: metabolic advantages of increased meal frequency. , 1989, The New England journal of medicine.

[26]  J. Ordovás,et al.  Postprandial plasma lipoprotein changes in human subjects of different ages. , 1988, Journal of lipid research.

[27]  F. Berr,et al.  Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women. , 1986, Journal of lipid research.

[28]  W. Kannel,et al.  Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. , 1986, American heart journal.

[29]  W. Kannel Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. , 1985, American heart journal.

[30]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.